William S Marth Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for William S Marth.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of William S Marth. William S Marth is Director in Teligent, Inc. ($TLGT) and Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and President and CEO in ALBANY MOLECULAR RESEARCH INC ($AMRI) and Director in Sorrento Therapeutics, Inc. ($SRNE).

Latest Insider Trading Transactions of William S Marth

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMRI, SRNE, TLGT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 24 2021TLGTTeligent, Inc.Marth William SDirectorOption ExerciseA1.362,0002,7202,000
Sep 05 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOOption ExerciseD18.41133,6902,461,2330
Sep 05 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOOption ExerciseD15.7754,498859,4330
Sep 05 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOSellD21.75483,03310,505,9680483 K to 0 (-100.00 %)
Sep 05 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOSellJ0.0020,3830483,033503.4 K to 483 K (-4.05 %)
Sep 05 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOSellJ0.0018,4720503,416521.9 K to 503.4 K (-3.54 %)
Jul 06 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA16.0488414,179521,888521 K to 521.9 K (+0.17 %)
Feb 10 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOOption ExerciseA18.41133,6902,461,233133,690
Feb 10 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA0.0020,3830521,004500.6 K to 521 K (+4.07 %)
Feb 10 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA0.0027,1590500,621473.5 K to 500.6 K (+5.74 %)
Feb 07 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOPayment of ExerciseF18.521,94235,966473,462475.4 K to 473.5 K (-0.41 %)
Feb 07 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOPayment of ExerciseF18.5241,626770,914475,404517 K to 475.4 K (-8.05 %)
Jan 03 2017AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOPayment of ExerciseF18.638,425156,958517,030525.5 K to 517 K (-1.60 %)
Jul 12 2016SRNESorrento Therapeut ...Marth William SDirectorOption ExerciseA6.4449,000315,560182,000
Jul 07 2016AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA11.421,31214,983525,455524.1 K to 525.5 K (+0.25 %)
May 16 2016AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOBuyP12.8612,500160,750524,143511.6 K to 524.1 K (+2.44 %)
Feb 08 2016AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOOption ExerciseA15.7754,498859,43354,498
Feb 08 2016AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA16.794908,227510,668510.2 K to 510.7 K (+0.10 %)
Feb 08 2016AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA15.7771,3381,125,000510,178438.8 K to 510.2 K (+16.26 %)
Jan 04 2016AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOPayment of ExerciseF20.168,374168,820438,840447.2 K to 438.8 K (-1.87 %)
Jun 08 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOBuyP19.9810,000199,800447,214437.2 K to 447.2 K (+2.29 %)
Jun 08 2015SRNESorrento Therapeut ...Marth William SDirectorOption ExerciseA13.7958,000799,820133,000
Apr 08 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOOption ExerciseM5.9912,36774,0780
Apr 08 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOOption ExerciseM2.5910,00025,9000
Apr 08 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOBuyM5.9912,36774,078437,214424.8 K to 437.2 K (+2.91 %)
Apr 08 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOBuyM2.5910,00025,900424,847414.8 K to 424.8 K (+2.41 %)
Mar 06 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOBuyP17.7020,000354,000414,847394.8 K to 414.8 K (+5.07 %)
Mar 04 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA13.8494013,010394,847393.9 K to 394.8 K (+0.24 %)
Mar 04 2015AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA17.0558,6511,000,000393,907335.3 K to 393.9 K (+17.49 %)
Jan 03 2014AMRIALBANY MOLECULAR R ...Marth William SPresident and CEOGrantA10.0899,2071,000,007190,36691.2 K to 190.4 K (+108.83 %)
Dec 04 2013AMRIALBANY MOLECULAR R ...Marth William SDirectorBuyP10.7530,000322,50091,15961.2 K to 91.2 K (+49.05 %)
Nov 22 2013AMRIALBANY MOLECULAR R ...Marth William SDirectorBuyP11.5720,000231,40061,15941.2 K to 61.2 K (+48.59 %)
Jun 06 2013AMRIALBANY MOLECULAR R ...Marth William SDirectorGrantA10.462,86829,99941,15938.3 K to 41.2 K (+7.49 %)
Jun 04 2013AMRIALBANY MOLECULAR R ...Marth William SDirectorBuyP10.2310,000102,30038,29128.3 K to 38.3 K (+35.35 %)
Feb 04 2013AMRIALBANY MOLECULAR R ...Marth William SDirectorOption ExerciseA5.9912,36774,07812,367
Feb 04 2013AMRIALBANY MOLECULAR R ...Marth William SDirectorGrantA5.995,84335,00028,29122.4 K to 28.3 K (+26.03 %)
Dec 04 2012AMRIALBANY MOLECULAR R ...Marth William SDirectorBuyP5.0010,00050,00022,44812.4 K to 22.4 K (+80.33 %)
Jun 14 2012AMRIALBANY MOLECULAR R ...Marth William SDirectorOption ExerciseA2.5910,00025,90010,000
Jun 07 2012AMRIALBANY MOLECULAR R ...Marth William SDirectorGrantA2.4112,44830,00012,4480 to 12.4 K

Page:   1

Contact us | Follow us on Twitter